Type B - Karman Holdings Inc. (KRMN) 20261108 Stock Analysis
📅 Karman Key Upcoming Events
- February 05, 2027 Q4 and FY2026 Earnings Release (Estimated)
- Description: A financial-calendar projection places Karman’s next quarterly and annual results around February 5, 2027. Investors will focus on whether FY2026 revenue reaches management’s increased $755M-$760M guidance, whether adjusted reaches $225M-$227M, and how the $1.7B backlog converts into 2027 revenue. The date has not been officially confirmed and may change.
🏢 Step 1: Karman Company Overview & Business Model
Q1-A1. What is Karman?
- Company Name (Ticker): Karman Holdings Inc. (KRMN)
- Sector: Industrials
- Exchange: NYSE
- Founded: 2020 (incorporation year; exact founding day unavailable)
- Listing Date: February 13, 2025
- Fiscal Year End: December
- Headquarters: United States, Huntington Beach, California
- CEO: Jonathan Rambeau (Founder Status: No)
- Market Cap: $6.04B
- : 132.53M
- Current Price: $45.61
- Annual : ➖ Not applicable
- : ➖ Not applicable
- As-of: November 08, 2026 (ET)
Q1-A2. How Does Karman Make Money?
- Mission-Critical Defense and Space Subsystem Manufacturing: Karman designs, engineers, tests, and manufactures specialized components and integrated subsystems for missiles, hypersonic weapons, missile-defense interceptors, spacecraft, launch vehicles, and naval defense applications.
- Revenue Generation: Customers purchase engineered hardware, production assemblies, and development-related manufacturing services through program contracts, purchase orders, and long-term supply agreements. Revenue is generated as contractual performance obligations are fulfilled.
- Customer Base: Karman serves defense prime contractors, government-related defense programs, and commercial space customers. Its products support more than 150 customers across more than 150 programs.
- Competitive Positioning: Rather than competing primarily as a complete missile or spacecraft manufacturer, Karman supplies critical subsystems used by larger system integrators. This merchant-supplier model allows participation in multiple programs and platforms.
- Economic Mechanism: Qualification requirements, specialized manufacturing processes, program longevity, and high switching costs can create recurring production opportunities once components are incorporated into established defense systems.
Q1-A3. Karman’s Revenue Segments & Core Income Sources
- Q3 2026 End-Market Revenue: Total reported quarterly revenue was $201.62M. The following percentages use that consolidated denominator.
- Tactical Missiles and Integrated Defense Systems: $67.58M, representing 33.5% of revenue. Sales increased 51.9% YoY, supported by missile programs, unmanned aircraft systems, and counter-UAS applications.
- Hypersonics and Strategic Missile Defense: $51.10M, representing 25.3%. Revenue increased 39.6% YoY, reflecting demand for advanced propulsion-related and missile-defense capabilities.
- Maritime Defense Systems: $45.04M, representing 22.3%. This business supports submarine and surface-vessel programs. Prior-year comparisons are affected by reporting reclassification and acquisitions.
- Space and Launch: $37.91M, representing 18.8%. Revenue declined 6.9% YoY in the quarter, although nine-month revenue increased 8.5%.
- Revenue Mix Interpretation: Defense-oriented applications represented approximately 81.2% of quarterly revenue, with Space and Launch contributing the remaining 18.8%. This establishes defense procurement as Karman’s primary economic driver.
- Organic Versus Acquired Growth: Total Q3 revenue increased 65.6% YoY, while management reported approximately 25% . Acquisitions therefore contributed materially to consolidated expansion.
- Backlog Visibility: Backlog reached approximately $1.7B at September 30, 2026, up 108% from year-end 2025. This provides substantial contracted revenue visibility, although backlog timing, funding, and execution conditions determine actual conversion.
Q1-A4. Who Are Karman’s Competitors?
- Direct Specialized Competitors: Karman competes with specialized aerospace and defense subsystem manufacturers, precision-engineering suppliers, propulsion-component producers, and qualified contract manufacturers.
- Relevant Larger Industry Participants: Companies such as L3Harris, including its propulsion operations, and diversified aerospace suppliers participate in adjacent technical markets. Their broader businesses make them imperfect company-wide comparisons.
- Customer Competitors: Defense primes such as Lockheed Martin, RTX, and Northrop Grumman maintain internal engineering and production capabilities that can substitute for externally sourced components.
- Legacy Suppliers Most Exposed: Traditional single-program machining and component suppliers may lose opportunities when prime contractors consolidate work with integrated suppliers capable of handling engineering, qualification, and scaled manufacturing.
- Strategic Position: Karman is better characterized as a specialized consolidator and manufacturing partner than as a first mover creating an entirely new product category. Its growth strategy combines technical specialization, acquisitions, and expansion across existing defense programs.
Q1-A5. What Problem Does Karman Solve?
- Problem — Production Complexity: Advanced weapons and space systems require components that tolerate extreme temperature, pressure, vibration, acceleration, and mission-critical operating conditions. Qualification and production scaling are expensive and time-consuming.
- Solution — Integrated Engineering and Manufacturing: Karman combines specialized design, testing, manufacturing, and production capabilities, helping customers move programs from development into repeatable production.
- Customer Value: Qualified components reduce integration uncertainty and may shorten the time required to establish reliable manufacturing capacity.
- Traditional Alternative: Defense prime contractors can manufacture components internally or coordinate multiple smaller subcontractors. Karman offers an alternative through consolidated technical expertise and an established manufacturing network.
- Economic Limitation: Manufacturing remains capital-intensive. Technical differentiation does not eliminate material costs, labor requirements, investment, or dependence on procurement schedules.
Q1-A6. Karman Key Milestones: Past 12 Months
- November 2025 Continued Expansion of Defense and Space Manufacturing Operations
- Description: Karman entered the subsequent fiscal year with an expanding defense-oriented manufacturing platform. Continued acquisition integration and production scaling became central determinants of its financial performance.
- August 28, 2026 Completed Walker Precision Acquisition
- Description: Karman completed its acquisition of Walker Precision for approximately $95M in cash, expanding its European defense manufacturing footprint and strengthening exposure to missile guidance and control systems.
- September 16, 2026 Three Directors Purchased Common Shares
- Description: David Stinnett purchased 27,000 shares, Mary D. Petryszyn purchased 500 shares, and Stephen Twitty purchased 275 shares. The combined open-market purchases totaled 27,775 shares and approximately $1.04M, providing a positive alignment signal without establishing future share-price performance.
- November 05, 2026 Q3 FY2026 Earnings Release
- Description: Karman reported $201.62M in revenue, approximately $21M in net income, $61M in adjusted , and $13M in quarterly . Backlog reached $1.7B, and management increased its full-year guidance.
- November 06, 2026 Strong Post-Earnings Share-Price Rebound
- Description: Shares closed at $45.61, rising 42.13% from the prior session. The rebound followed strong operating results and came after a substantial preceding decline, highlighting significant equity volatility.
Q1-A7. Step 1 Key Takeaways
- Step 1 Summary: Karman is a rapidly expanding supplier of highly engineered defense and space subsystems, supported by strong organic growth, acquisitions, and record backlog. Its opportunity is substantial, but acquisition integration, working-capital demands, leverage, and unusual stock volatility remain critical considerations.
🌲 Step 2: Karman’s , Market Size & Scalability
Q2-A1. Does Karman Have a Durable Economic Moat?
- Technical Qualification Barriers: Mission-critical defense components require extensive testing, engineering experience, quality controls, and manufacturing qualifications. These requirements restrict the number of suppliers capable of producing approved components.
- Switching Costs: Replacing a qualified subsystem supplier can require engineering redesign, testing, approval, and manufacturing validation. Such processes can make supplier replacement expensive and operationally disruptive.
- Program Entrenchment: Participation in more than 150 programs creates a diversified foundation of customer relationships and opportunities for follow-on production.
- Network Effects: Karman does not possess a conventional digital-platform network effect. Its advantage comes from accumulated engineering capabilities, program qualifications, and manufacturing infrastructure.
- Pricing Power: Specialized components can support attractive margins, although defense procurement negotiations and large prime contractors constrain unrestricted pricing.
- Moat Limitation: Larger competitors may possess greater engineering resources, capital availability, and vertically integrated manufacturing capabilities. Karman’s competitive advantage therefore depends on maintaining qualification, cost discipline, and execution reliability.
Q2-A2. How Big Is Karman’s Market? ()
- Addressable Market Definition: Karman participates in multiple overlapping markets, including hypersonic weapons, strategic missile defense, tactical missile systems, naval defense components, spacecraft, and launch-vehicle subsystems.
- Demand Environment: Increased missile-defense modernization, counter-UAS procurement, strategic deterrence investment, and expanding space-launch activity support structural demand for specialized manufacturing.
- TAM Measurement: A single verified, non-overlapping revenue TAM covering Karman’s specific subsystem opportunities is unavailable. Broad defense spending cannot be treated as fully addressable company revenue because Karman captures only selected component and manufacturing expenditures.
- Market Growth Outlook: Management’s long-term objective of 20%-25% provides a company-specific operating ambition, not an independently established growth rate for the entire addressable market.
- Commercial Opportunity: With approximately $669M in trailing revenue and $1.7B in reported backlog, Karman has evidence of meaningful customer demand and potential for continued market-share expansion.
- Opportunity Limitation: Defense funding, qualification timelines, customer concentration, and manufacturing capacity constrain the portion of theoretical demand that can become profitable revenue.
Q2-A3. How Real Is Karman’s TAM? (Quality Check)
- Willingness to Pay: Defense customers prioritize mission reliability, technical performance, supplier qualification, and program execution. This supports willingness to purchase specialized components when they satisfy critical performance requirements.
- Market Structure: The market contains large system integrators and a smaller set of technically qualified subsystem suppliers. Competitive advantages arise from specialization and approved production capacity rather than winner-takes-all economics.
- Regulation and Entry Barriers: Defense procurement requirements, export controls, security obligations, and technical qualification processes create meaningful entry barriers.
- Profitability Evidence: Q3 adjusted of approximately $61M on $201.62M of revenue implies an adjusted EBITDA margin of approximately 30.3%.
- Market Quality Assessment: High engineering requirements and long-duration programs support attractive revenue economics, but government funding cycles and prime-contractor bargaining power limit pricing flexibility.
Q2-A4. Can Karman Keep Expanding Its Market?
- Current Market Penetration: A defensible percentage of total addressable market penetration cannot be calculated because comparable market revenue and Karman-specific addressable spending are not consistently defined.
- Backlog Expansion: Backlog increased 108% from year-end 2025 to approximately $1.7B at September 30, 2026, demonstrating significant growth in contracted opportunities.
- International Expansion: Walker Precision provides a manufacturing foothold in Europe and broader access to allied defense programs.
- Cross-Program Expansion: Existing technical capabilities can be applied across missile, hypersonic, maritime, and space applications, allowing incremental revenue opportunities without entering entirely unrelated industries.
- Scalability Constraint: Manufacturing requires facilities, skilled workers, equipment, quality systems, and . Revenue growth does not occur at near-zero marginal cost.
- Long-Term Expansion Potential: Karman can grow through new program awards, second-source opportunities, production-volume increases, and selective acquisitions, provided returns exceed the additional capital required.
Q2-A5. Step 2 Key Takeaways
- Scoring Rationale:
- Economic Moat (8/10): Technical qualification, program entrenchment, and substantial switching costs establish defensible advantages, although larger suppliers can compete.
- Market Size (4/5): Defense modernization and space demand support a substantial opportunity, despite the absence of a precisely defined subsystem TAM.
- Market Quality·Profitability (6/7): Mission-critical components and a roughly 30% adjusted EBITDA margin indicate attractive economics, constrained by customer bargaining power and procurement cycles.
- Market Penetration·Scalability (6/8): Strong backlog and international expansion support growth, while capital-intensive manufacturing limits scalability.
- 📊 Step 2 Score: 24/30 pts (Economic Moat 8/10 + Market Size 4/5 + Market Quality·Profitability 6/7 + Market Penetration·Scalability 6/8)
- Step 2 Summary: Karman possesses meaningful technical and qualification-based competitive advantages within expanding defense markets. Its growth potential is attractive but depends on successful manufacturing execution rather than software-like scalability.
🚀 Step 3: How Fast Is Karman Growing? Hyper-Growth Metrics
Q3-A1. How Fast Is Karman Growing? (Revenue Trajectory)
- Strong Multi-Year Revenue Expansion: Revenue increased from $345.25M in FY2024 to $471.50M in FY2025, representing 36.6% growth. Trailing revenue reached $669.39M through September 2026, up 56.3% year over year.
- Quarterly Growth Accelerated: Q2 2026 revenue reached $182.06M, up approximately 58.2% YoY and 20.4% sequentially from Q1 revenue of $151.21M. Q3 revenue increased to $201.62M, up 65.6% YoY and 10.7% sequentially. The year-over-year growth rate accelerated, although sequential growth moderated.
- Remained Strong: Management reported approximately 24.4% organic growth in Q2 and 25% in Q3. The significantly higher consolidated growth rates reflect acquisition contributions as well as underlying demand.
- Growth-Curve Position: Karman is in a rapid manufacturing expansion phase rather than a conventional early-stage software J-curve. Its economic trajectory depends on production capacity, funded orders, acquisitions, and conversion of programs into recurring manufacturing revenue.
- Growth Interpretation: Rising organic growth and backlog support a favorable operating trajectory. Nevertheless, the distinction between organic and acquired growth is essential when judging sustainable expansion.
Q3-A2. Karman’s Key Growth Metrics
- Selected Manufacturing Growth Indicators: Backlog, bookings, organic revenue growth, and adjusted margins are the most relevant indicators because Karman expands through contracted, technically qualified production programs.
- Backlog: Approximately $1.7B at September 30, 2026, representing 108% growth from year-end 2025 and about 2.5 times trailing revenue.
- Quarterly Bookings: Nearly $465M in Q3, equivalent to approximately 2.3 times quarterly reported revenue. This is a strong single-quarter order signal, not necessarily a sustainable recurring bookings rate.
- Organic Revenue Growth: Approximately 25% in Q3, supporting management’s longer-term organic growth ambition of 20%-25%.
- Adjusted EBITDA Growth: Q3 adjusted EBITDA increased 60% YoY to approximately $61M.
- Growth Quality Assessment: The combination of strong organic demand, substantial orders, and expanding production supports the growth case. Acquisition integration and the timing of backlog conversion remain important qualifications.
Q3-A3. Are Karman’s Unit Economics Improving?
- Expansion: FY2025 gross profit of $190.03M on $471.50M revenue implies a gross margin of approximately 40.3%. Trailing gross profit of $281.87M on $669.39M revenue implies approximately 42.1%, indicating improved production economics.
- : Operating income increased from $72.94M in FY2025 to $110.90M on a trailing basis. The corresponding operating margin improved from approximately 15.5% to 16.6%.
- Adjusted Profitability: Q3 adjusted EBITDA margin was approximately 30.3%, compared with strong profitability in the preceding quarter.
- Rule of 40 Diagnostic: Trailing revenue growth of 56.3% combined with a trailing margin of -1.1% produces approximately 55.2%. This exceeds 40%, but the metric is less informative for an acquisition-intensive manufacturer than for a software business.
- : Not economically suitable as a primary measure because Karman acquires long-duration industrial programs through engineering qualification and procurement rather than subscription customer acquisition.
- Capital Conversion: Improving gross and operating margins have not yet produced consistently positive trailing free cash flow. absorption and increased weaken the conversion of accounting profits into distributable cash.
Q3-A4. Step 3 Key Takeaways
- Scoring Rationale:
- Revenue Growth Acceleration (9/12): Consolidated growth accelerated to 65.6% YoY in Q3, supported by approximately 25% organic expansion, although acquisitions amplify the headline trajectory.
- Sector-Specific Growth Metrics (9/10): Record backlog, unusually strong bookings, and continuing organic growth provide convincing evidence of production demand.
- Unit Economics·Margin (6/8): Gross and operating margins improved, but weak trailing free cash flow limits the quality of economic conversion.
- 📊 Step 3 Score: 24/30 pts (Revenue Growth Acceleration 9/12 + Sector-Specific Growth Metrics 9/10 + Unit Economics·Margin 6/8)
- Step 3 Summary: Karman demonstrates exceptional revenue growth for a specialized manufacturer, supported by expanding backlog and favorable margin trends. Cash conversion and acquisition-adjusted profitability remain the main qualifications.
💪 Step 4: Karman’s Profit Potential &
Q4-A1. Can Karman Turn Growth Into Profit?
- Established Profitability: Karman is already profitable rather than approaching an initial break-even point. Q3 2026 net income increased approximately 174% YoY to $21M.
- : Trailing operating income of $110.90M increased substantially relative to FY2025’s $72.94M, while improved from approximately 15.5% to 16.6%.
- Adjusted Earnings Expansion: Q3 adjusted reached $61M, an increase of approximately 60% YoY.
- Profit Conversion Limitations: Acquired intangible amortization, financing expenses, and integration costs affect the difference between adjusted EBITDA and GAAP net income.
- Profitability Outlook: Management’s revised FY2026 adjusted EBITDA guidance of $225M-$227M on revenue of $755M-$760M implies a margin near 29.9% at the respective midpoints.
- Assessment: Karman has demonstrated meaningful profitability and expanding production scale, but further growth must translate into sustained after-interest cash generation to establish attractive shareholder economics.
Q4-A2. Does Karman Generate Free Cash Flow?
- Quarterly Cash Flow Improvement: Q3 was approximately $27M and reported free cash flow was $13M, demonstrating that the business can generate positive cash during favorable collection periods.
- Trailing Cash Flow: Operating cash flow totaled approximately $32.46M during the through September 2026, while was approximately $39.92M.
- Trailing FCF Calculation: Operating cash flow of $32.46M minus capital expenditure of $39.92M equals approximately -$7.46M in trailing free cash flow.
- Historical Comparison: FY2025 free cash flow was approximately -$42.46M, versus positive $11.39M in FY2024. The improvement in the latest trailing period is significant, but sustained positive annual cash generation has not yet been demonstrated.
- Pressure: Approximately $90.47M of trailing cash was absorbed by changes in accounts receivable, reflecting the financing requirements associated with rapid sales growth.
- Capital Funding: Significant acquisitions and increased manufacturing capacity have required external financing. Operating cash flow currently covers only part of total growth investment and acquisition spending.
- Cash Flow Conclusion: Cash generation is improving, but Karman has not yet established a consistently self-funding growth model.
Q4-A3. Step 4 Key Takeaways
- Scoring Rationale:
- Operating Leverage·Path to Profit (6/8): GAAP profitability and expanding adjusted EBITDA demonstrate operating leverage, although financing and acquisition costs dilute shareholder earnings.
- FCF·Capital Efficiency (5/7): Positive Q3 cash generation and substantial improvement from FY2025 support progress, but trailing FCF remains slightly negative.
- 📊 Step 4 Score: 11/15 pts (Operating Leverage·Path to Profit 6/8 + FCF·Capital Efficiency 5/7)
- Step 4 Summary: Karman has moved beyond the profitability-validation stage, with increasing revenue and operating margins. The next milestone is turning its stronger operating earnings into durable positive free cash flow while managing acquisition-related leverage.
👔 Step 5: Karman Management & Shareholder Alignment
Q5-A1. Who Leads Karman? (Founder & Management)
- Leadership: Jonathan Rambeau serves as Chief Executive Officer. Karman’s current organization reflects a consolidation and expansion strategy rather than a single founder-operated startup structure.
- Strategic Vision: Management aims to become a preferred independent manufacturing partner for mission-critical defense and space programs, combining technical engineering, accelerated production, and selective acquisitions.
- Guidance Execution: Following strong Q3 results, management raised FY2026 revenue expectations to $755M-$760M and adjusted expectations to $225M-$227M.
- Operating Commitments: Management highlighted a long-term organic revenue growth objective of 20%-25%, additional long-term agreement negotiations, and multiple second-source opportunities.
- Guidance Reliability: The latest increase supports management credibility, but the public-company track record remains relatively short following the February 2025 IPO.
- Execution Assessment: Management has demonstrated strong recent production growth and acquisition activity. Delivering profitable backlog conversion, international integration, and cash-flow improvement will be the primary tests of accountability.
Q5-A2. Is Karman’s Management Aligned With Shareholders?
- Insider Ownership: Reported insider ownership was approximately 17.1%, indicating meaningful economic exposure to the company’s equity performance.
- Confirmed Open-Market Purchases:
- David Stinnett, Director: Purchased 27,000 shares on September 16, 2026, at approximately $37.32 per share, totaling about $1.01M.
- Mary D. Petryszyn, Director: Purchased 500 shares on September 16, 2026, at approximately $37.44 per share.
- Stephen Twitty, Director: Purchased 275 shares on September 16, 2026, at approximately $36.79 per share.
- Net Insider Signal: The identified September purchase cluster represented 27,775 shares and approximately $1.04M of open-market buying. A complete net trading total covering all insider and affiliated-holder transactions over the trailing year was not established, so these purchases should not be interpreted as comprehensive net accumulation.
- Equity Compensation: Recent share-award disclosures included approximately 11,358 shares granted to CFO Chris Michael Boynton and 5,514 shares awarded to Chief Growth Officer Doug Laurendeau. Grants differ from voluntary open-market purchases.
- Shareholder : increased modestly from approximately 132.32M at December 2025 to 132.53M at September 2026. This represents less than 0.2% growth over that nine-month period.
- Governance Considerations: Insider ownership and director purchases support alignment. Nevertheless, concentrated ownership and acquisition-oriented capital allocation require ongoing scrutiny of related-party transactions, executive incentives, and long-term returns on invested capital.
Q5-A3. Step 5 Key Takeaways
- Scoring Rationale:
- Founder Management·Vision (5/8): Management presents a coherent mission-critical manufacturing strategy and has raised guidance, although the company is not founder-CEO-led and its public operating record is limited.
- Alignment·Accountability (5/7): Meaningful insider ownership, director purchases, and controlled recent dilution are favorable, balanced against ownership concentration and acquisition execution risks.
- 📊 Step 5 Score: 10/15 pts (Founder Management·Vision 5/8 + Alignment·Accountability 5/7)
- Step 5 Summary: Karman’s leadership demonstrates credible operating momentum and meaningful insider equity exposure. The primary governance test is whether management translates acquisition-driven expansion into durable per-share cash generation.
⛵ Step 6: Karman Market Flow & Sentiment
Q6-A1. vs Karman Guidance
- Management Revenue Guidance: FY2026 revenue is expected to reach $755M-$760M, with a midpoint of $757.50M.
- Compiled Revenue Consensus: The available FY2026 estimate of approximately $748.79M was below management’s newly increased midpoint by approximately $8.71M, or 1.2%. The estimate snapshot may not fully incorporate the November 5 guidance revision.
- Adjusted Guidance: Management expects $225M-$227M in FY2026 adjusted EBITDA, implying approximately $226M at the midpoint.
- Expectations: Compiled FY2026 adjusted EPS expectations were approximately $0.59, increasing toward $0.96 for FY2027. These estimates are distinct from and should not be treated as directly interchangeable.
- Recent Estimate Revisions: Compiled revenue expectations rose modestly over recent one- and three-month observation windows, with FY2027 revenue estimates around $956M. The rapid upward shift in company guidance is more recent than some published consensus snapshots.
- Analyst Positioning: Fourteen analysts contributed to the available rating distribution, with ten Strong Buy and four Buy ratings. Their average twelve-month target was approximately $71.46, an external consensus rather than an independently derived intrinsic-value estimate.
- Sentiment Assessment: Operating momentum supports favorable fundamental expectations, but the stock’s rapid rebound and previously severe decline indicate unstable short-term positioning.
Q6-A2. What Is Karman’s ?
- Short Selling Exposure: A market-positioning snapshot indicated approximately 15.09M shares sold short, equivalent to roughly 51% of its narrower estimated tradable float.
- : Reported days-to-cover was approximately 5.26 trading days, indicating meaningful short positioning relative to recent average trading volume.
- Float Definition: Float estimates differ materially across providers, with one broader dataset indicating approximately 102.64M shares while a narrower effective-tradable-float calculation was about 29.57M shares. The 51% short-interest ratio must therefore not be applied to the broader float denominator.
- Institutional Positioning: Reported institutional ownership exceeded 100% of outstanding shares in one compiled snapshot. This is a filing-based aggregation artifact affected by reporting dates, lending, and overlapping classifications rather than literal ownership of more than all existing shares.
- Potential: High short positioning and limited effective tradable supply can amplify upward price movements. The 42.13% gain on November 6 is consistent with unusually volatile trading, although the contribution of short covering cannot be independently isolated.
- Risk Interpretation: Elevated short interest supports the possibility of sharp squeezes and reversals but is not itself evidence of stronger intrinsic value.
Q6-A3. Step 6 Key Takeaways
- Scoring Rationale:
- Consensus vs Guidance (2/3): Increased guidance and favorable earnings surprises support sentiment, although extreme share-price volatility and stale estimate snapshots reduce interpretive clarity.
- Supply·Short Interest (2/2): Significant documented short positioning and strong trading activity provide clear evidence of meaningful market-flow catalysts.
- 📊 Step 6 Score: 4/5 pts (Consensus vs Guidance 2/3 + Supply·Short Interest 2/2)
- Step 6 Summary: Management’s improving operating outlook supports analyst expectations, while extreme short positioning creates unusually strong sensitivity to changes in sentiment and earnings expectations.
🧨 Step 7: Karman Catalysts & Price Triggers
Q7-A1. What Could Re-Rate Karman Stock? (Next 12 Months)
- 1 Conversion of Record Defense Backlog Into Revenue
- Timing: FY2027 production updates and subsequent earnings releases.
- Success Conditions: Karman converts its $1.7B backlog into sustained near management’s 20%-25% objective while maintaining approximately 30% adjusted margins.
- Failure Risk: Contract delays, funding constraints, or production bottlenecks slow backlog conversion and weaken revenue visibility.
- 2 Expansion of THAAD and Other Long-Term Defense Programs
- Timing: Over the next 6-12 months as program activity and long-term agreement negotiations develop.
- Success Conditions: The seven-year Lockheed Martin THAAD-related agreement and additional production opportunities lead to stronger contracted revenue and manufacturing utilization.
- Failure Risk: Procurement changes or execution delays reduce the anticipated economic contribution.
- 3 Successful Integration of Walker Precision and Other Acquired Operations
- Timing: FY2027 integration and financial reporting.
- Success Conditions: European manufacturing capabilities generate incremental revenue, operating efficiencies, and broader access to allied defense programs.
- Failure Risk: Integration costs, operational complexity, and additional leverage offset acquisition-driven growth.
Q7-A2. Karman’s Estimate Revision Trend
- Revenue Revision Direction: Available compiled FY2027 revenue estimates increased approximately 2.1% over the preceding three months, reaching approximately $956M in the more recent forecast snapshot.
- Revision Direction: FY2027 EPS estimates increased approximately 5.4% over the same three-month interval in one comparable estimate series, reflecting improving expected profitability.
- Latest Operating Evidence: Q3 revenue exceeded the contemporaneous reported estimate of approximately $194.74M, while adjusted EPS of $0.19 exceeded the approximately $0.15 consensus.
- Revision Implications: Strong bookings, backlog expansion, and increased FY2026 guidance support upward pressure on future forecasts, although the impact of acquired revenue and financing must be considered.
- Forward Assessment: Estimate momentum is favorable, but Karman must demonstrate that expected earnings growth can be converted into cash flow and sustained without proportionate increases in leverage.
Q7-A3. Step 7 Key Takeaways
- Scoring Rationale:
- Catalyst Strength (2/3): Record backlog, defense program awards, and international expansion provide credible catalysts, but their financial realization requires execution.
- Estimated Trend (2/2): Recent revenue and EPS estimate revisions have been favorable, reinforced by Q3 results and management’s increased guidance.
- 📊 Step 7 Score: 4/5 pts (Catalyst Strength 2/3 + Estimated Trend 2/2)
- Step 7 Summary: Karman has multiple identifiable catalysts supported by actual operating developments. The strongest rerating opportunity comes from profitable backlog conversion rather than speculative new-market entry.
⚖️ Step 8: Is Karman Fairly Valued? Valuation Analysis
Q8-A1. Karman’s Key Valuation Multiples
- : 9.03x (overvalued) — The premium is substantial for a capital-intensive manufacturer, even with strong .
- : N/A (not applicable) — Negative trailing makes a positive valuation multiple economically uninformative.
- : 186.24x (very overvalued) — remains low relative to equity valuation because of absorption.
- : 10.44x (overvalued) — The multiple assumes strong continuing growth and significant long-term operating profitability.
- : 40.66x (overvalued) — The trailing multiple is demanding relative to established industrial manufacturers.
- : N/A (not applicable) — Negative trailing FCF prevents a meaningful positive multiple.
- : 51.61x (overvalued) — The forward earnings premium requires rapid earnings expansion.
- : 0.29x (fairly valued) — The low mechanically calculated growth-adjusted ratio reflects unusually high forecast earnings growth and should not be interpreted as an independent .
- Scoring Rationale: Karman’s strong organic growth, backlog, and margins justify a premium to ordinary manufacturing businesses. However, negative trailing FCF, material leverage, and substantial multiples indicate that future execution remains heavily priced into the shares.
- 📌 (1) Axis Q8-A1 Score: -3
Q8-A2. Karman vs Peers: Valuation Comparison
- Multiple selection based on peer comparison: EV/EBITDA is appropriate for comparing specialized aerospace and defense manufacturers because it reduces distortions from different financing structures, while still requiring alignment of acquisition accounting and adjustments. Relevant comparison candidates include specialized defense suppliers and diversified aerospace manufacturers with similar production economics.
- Calculation of peer-to-peer deviation rate: A defensible current arithmetic peer mean could not be established across consistently dated, same-definition EBITDA observations, so no numerical deviation is assigned.
- 🧮 Calculation Formula: ((Karman EV/EBITDA 40.66x - comparable peer mean) / comparable peer mean) × 100; the peer mean is unavailable on a sufficiently comparable basis.
- Scoring Rationale: Karman’s high growth can justify a premium to slower-growing industrial peers, but comparing its trailing EBITDA directly with adjusted or forward EBITDA from diversified defense contractors would create an unreliable deviation. The absence of an adequate common-basis peer set leaves this comparative axis unscored.
- 📌 (2) Axis Q8-A2 Score: 0
Q8-A3. What Is Karman Worth in the Future? (Forward Valuation)
- Implied Future Multiple: At approximately $6.99B in current enterprise value, divided by an illustrative FY2028 adjusted EBITDA estimate of $368M, Karman trades at an undiscounted diagnostic multiple of approximately 19.0x FY2028 EBITDA. Applying a 10% annual enterprise-value discount rate over approximately two years produces a comparable future-date valuation burden of approximately 23.0x FY2028 EBITDA.
- Scoring Rationale: Forecast FY2028 revenue of approximately $1.20B and adjusted EBITDA of $368M require continued robust growth, integration execution, and margins above 30%. A roughly 23.0x future-date EBITDA burden remains demanding for a capital-intensive and leveraged supplier, even though its defense exposure supports a premium. The forecast assumes material growth beyond current company guidance and is sensitive to backlog conversion.
- 📌 (3) Axis Q8-A3 Score: -2
Q8-A3-1. What Growth Hurdle Does the Market Demand From Karman? (Forward Valuation Alternative)
- Scoring Rationale: Not applicable — a forward valuation can be constructed from current enterprise value, identified FY2028 operating estimates, and an explicit time-value adjustment.
- 📌 (3) Axis Q8-A3-1 Score: ➖
Q8-A4. Final Valuation Adjustment
- Scoring Rationale: Karman’s record backlog and substantial defense program opportunities support elevated growth expectations, but those benefits already contribute to the operating forecasts and valuation multiples. No separate extraordinary adjustment is warranted without double-counting the same demand drivers.
- 📌 (4) Axis Q8-A4 Score: 0
Q8-A5. Valuation Adjustment Score Calculation
- Calculation Process:
- (1) Axis (Key Valuation Indicator): -3 pts (Overvalued)
- (2) Axis (Peer-to-peer deviation rate): 0 pts (Comparable peer deviation unavailable)
- (3) Axis (Justification of Growth): -2 pts (Future-date valuation remains demanding relative to forecast operating economics)
- (4) Axis (Final adjustment): 0 pts (No separately justified adjustment)
- 📊 Valuation Adjustment Score: A1 (-3) + A2 (0) + A3 (-2) + A4 (0) = -5 pts
- Commentary: Karman’s rapid revenue growth and record backlog provide a credible operating foundation, but its valuation still requires substantial future earnings expansion. The combination of acquisition-related leverage, negative trailing FCF, and elevated forward multiples limits the margin of safety.
- Step 8 Summary: Karman is a high-growth defense manufacturing business trading at a substantial premium to conventional industrial economics. Continued operating growth can support valuation recovery, but execution risk remains important.
💀 Step 9: What Are the Risks of Karman? Fatal Risks & Pre-Mortem
Q9-A1. Is Karman Burning Cash & Diluting Shareholders?
- Cash Generation: Trailing was positive at approximately $32.46M, but $39.92M in resulted in approximately -$7.46M of trailing . The company is not exhibiting a sustained operating cash collapse, but its investment requirements exceed current free cash generation.
- Liquidity Position: At September 30, 2026, cash and equivalents totaled approximately $68.17M, while current assets of $452.54M exceeded current liabilities of $146.11M. The of approximately 3.10x supports near-term liquidity.
- Debt Burden: Term debt, together with finance leases, represents a material financing burden. Debt to trailing was approximately 5.77x under the standardized debt definition, and was approximately 1.94x.
- History: increased from approximately 132.32M at year-end 2025 to 132.53M at September 2026, indicating modest recent net issuance.
- Future Dilution Risk: Equity compensation, acquisition financing, and concentrated ownership can create future share-supply risks, although no imminent large equity issuance or distressed financing event has been established.
- Risk Assessment: The immediate concern is financing and efficiency rather than habitual dilution. Sustained profitability and improved collections would materially reduce this exposure.
Q9-A2. Do Competition or Regulation Threaten Karman?
- Prime Contractor Bargaining Power: Large defense contractors control program architectures, supplier selection, and purchasing terms. Karman’s technical qualifications provide leverage, but major customers may seek alternative suppliers or insource selected capabilities.
- Defense Procurement Dependence: Program delays, funding changes, export restrictions, and contract modifications can affect production schedules and .
- Manufacturing Execution: Specialized production relies on skilled labor, qualification compliance, material availability, and dependable manufacturing yields. Failures can create costly delays and customer penalties.
- Acquisition Integration: Expansion into new manufacturing platforms and Europe increases organizational complexity and exposes Karman to integration expenses, currency effects, and additional operating oversight.
- Competitive Monitoring: The critical indicators are program retention, new awards, organic revenue growth, backlog conversion, contract margins, and cash collections.
Q9-A3. Karman Pre-Mortem: What Could Go Wrong?
- 1 Backlog conversion slows materially: Large contracted programs experience funding or production delays, causing reported growth to fall well below current expectations.
- Early Warning Signal: Two consecutive quarters of weakening accompanied by declining backlog conversion and reduced .
- 2 Acquisition and financing costs overwhelm operating improvements: Integration spending, debt service, and working-capital requirements prevent strong adjusted EBITDA from becoming sustainable free cash flow.
- Early Warning Signal: Persistently negative FCF combined with increasing net leverage and deteriorating interest coverage.
- 3 Defense customers shift production or reduce sourcing commitments: Larger system integrators internalize specialized production or redirect contracts to competing qualified suppliers.
- Early Warning Signal: Material program losses, weaker trends, or cancellation of significant long-term agreements.
Q9-A4. Risk Adjustment Score
- Reason for Scoring: Karman faces continuing acquisition-integration, procurement, and financial-execution risks. Its trailing FCF remains negative and debt is substantial, but strong backlog, positive operating cash flow, and a current ratio above 3x provide meaningful offsets. No imminent funding failure, structural loss of competitiveness, or independently established severe operating has been identified.
- 📊 Risk Adjustment Score: -4 pts
- Step 9 Summary: The main non-valuation risk is that rapid growth may require more working capital and financing than the business can comfortably generate. Strong demand and improving margins mitigate, but do not eliminate, that exposure.
🎯 Step 10: Karman Final Verdict: Score & Rating
Q10-A1. Investment Score & Rating
- Investment Score Calculation Formula:
- Step breakdown: S2 (24) + S3 (24) + S4 (11) + S5 (10) + S6 (4) + S7 (4) = 77 pts
- Steps 2-7 Sum (77 pts) + Valuation Adjustment (-5 pts) + Risk Adjustment (-4 pts) = Investment Score 68 pts
- Investment Score & Rating: 68 pts (B Rating ⭐⭐⭐)
- Commentary: Karman benefits from substantial technical barriers, strong organic demand, record backlog, and improving operating profitability. Its investment attractiveness is moderated by aggressive valuation, debt obligations, uneven , and the complexities of acquisition-driven expansion.
Q10-A2. Should You Buy Karman? (Recommendation)
- Recommendation: Hold
- Commentary: Karman’s operating momentum supports continued participation in the defense manufacturing growth cycle, but its current valuation leaves limited protection against weaker backlog conversion or financing pressure. Existing shareholders can monitor improving cash generation, while new investors may prefer a more favorable entry valuation.
Q10-A3. Investment Thesis in One Line
- Karman offers strong structural growth through mission-critical defense systems and record backlog, but elevated valuation, acquisition leverage, and uneven cash conversion limit its near-term .
Q10-A4. Karman’s Price Trend & Key Drivers
- Stock Price Trend Over the Past 12 Months: Highly Volatile, Net Declining 📉 — Shares declined approximately 39% from the November 2025 comparison level near $74.98 to $45.61 on November 6, 2026, despite an extraordinary rebound in the final trading session.
- August 2026 Strong Operating Growth and Updated Defense Manufacturing Outlook
- Description: Karman reported Q2 revenue of $182.06M, driven by approximately 24.4% and continued acquisition contributions.
- Stock Price Reaction: Broader Downtrend 📉 — Despite strong operating growth, the stock’s price during the following months weakened materially, with the November 6 quotation below its early-August comparison level.
- November 05, 2026 Q3 Earnings Release and Increased Guidance
- Description: Karman reported record quarterly revenue, improved profitability, substantial backlog growth, and higher FY2026 guidance.
- Stock Price Reaction: Sharp Rebound 📈 — Following the after-market announcement, shares rose 42.13% in the November 6 session, from $32.09 to $45.61. The trading response was consistent with a dramatic sentiment reversal, although the proportion attributable to short covering is unconfirmed.
Q10-A5. Action Plan
- Current Price: $45.61
- Buy Zone: $41.00 ($39.00–$43.00)
- (1) Calculation of Fundamental Value: A conservative accumulation range below the independently estimated base-case target provides a buffer against volatility, elevated leverage, and uncertainty surrounding the speed of FY2027 earnings realization.
- (2) Momentum Premium/Discount Application: Strong defense demand and the sharp post-earnings rebound justify monitoring entry opportunities above the October trading lows, but the unusually volatile price action does not support paying a large momentum premium.
- (3) Conclusion: A $39.00-$43.00 range, with a $41.00 midpoint, balances a discount to the modeled target against the probability of continued high stock-price volatility.
- Price Target: $51.94
- Expected Return: +13.9% (vs. current price)
- 📍 Selected Valuation Metric: FY2027 adjusted multiple — a manufacturing-oriented valuation that incorporates forward production scale and enterprise financing obligations.
- 🧮 Price Target Calculation Formula: (($289M FY2027E adjusted EBITDA × 27.0x) - $920M assumed and finance-lease obligations) / 132.53M shares = $51.94
- ⚓ Valuation Basis and Key Assumptions: The base case uses an approximately $289M FY2027 adjusted EBITDA estimate, consistent with the broader forecast of continued revenue expansion toward $956M and margins near 30%. The 27.0x multiple is an analytical premium reflecting defense qualification barriers, high organic growth, and contracted production visibility, rather than a measured current peer average. The $920M financing adjustment approximates September 2026 term debt and finance leases net of cash; it assumes no substantial incremental acquisition leverage. Unlike the current-value diagnostic in Q8-A3, the target uses a nearer FY2027 operating base and a lower enterprise multiple; the higher future operating earnings support the target despite the ongoing valuation premium. Changes in backlog conversion, acquisition financing, EBITDA margins, or share count could materially affect this estimate.
- Conditions and timing for reaching price target: Over the next 6-12 months, the target depends on confirmation of FY2026 guidance in the estimated February 2027 earnings release and subsequent FY2027 disclosures demonstrating sustained organic growth, strong backlog conversion, and improving free cash flow.
- Stop Loss: $34.00 ($33.00–$35.00)
- Action trigger upon catalyst achievement:
- 1 FY2026 guidance is achieved and FY2027 organic growth remains near management’s long-term objective
- Description: Confirm that growth is accompanied by stable adjusted EBITDA margins and improving cash generation before increasing exposure. 👉 Maintain Holdings (Hold)
- 2 Backlog conversion materially exceeds expectations without additional leverage
- Description: Stronger operating profitability and better free cash flow would support reconsidering the valuation and accumulation strategy. 👉 Consider Adding (Buy)
- 3 Share-price appreciation substantially exceeds operating estimate revisions
- Description: A valuation-driven rally without corresponding improvements in cash generation reduces expected future returns. 👉 Consider Partial Profit-Taking (Sell)
- 1 FY2026 guidance is achieved and FY2027 organic growth remains near management’s long-term objective
- Action trigger upon risk realization:
- 1 Two consecutive quarters of significant organic growth deterioration
- Description: Reassess the growth thesis if program delays or competitive losses weaken recurring production demand. 👉 Reduce Holdings (Sell)
- 2 Net leverage increases while trailing FCF remains negative
- Description: Rising financing obligations without corresponding cash generation materially weaken shareholder economics. 👉 Reduce Holdings (Sell)
- 3 Temporary working-capital pressure occurs without guidance deterioration
- Description: If liquidity remains adequate and backlog conversion is intact, avoid treating a single weak cash-flow quarter as structural . 👉 Maintain Holdings (Hold)
- 1 Two consecutive quarters of significant organic growth deterioration
- Customized Strategy Guide by Investment Preference:
- Defensive Investors: Prefer limited or no new exposure until positive trailing FCF and lower leverage demonstrate more resilient financial performance.
- Neutral Investors: Consider phased accumulation within the indicated Buy Zone, with the position sized for substantial volatility and reassessed after subsequent earnings releases.
- Aggressive Investors: May consider smaller staged positions during volatility, but should monitor changes, program awards, and the predefined downside range closely.
🕵️♂️ Deep Dive Analysis
Q1: Is Karman’s Acquisition-Driven Expansion Creating a Cash-Flow Weakness Despite Record Revenue Growth?
- Analysis: Karman’s consolidated revenue growth of 65.6% in Q3 substantially exceeded its approximately 25% , demonstrating that acquisitions contribute materially to the headline expansion. Its trailing remained negative at approximately $7.46M even as reported operating income improved. Receivables and contract assets also increased, reflecting the cash investment required to support higher production volumes. Acquisition-related debt and finance leases further reduce financial flexibility. The favorable scenario involves backlog conversion improving cash receipts and reducing net leverage. The adverse scenario involves additional investment and borrowing requirements persisting despite reported earnings growth.
- Judgment: Neutral — Acquisition-driven expansion is strategically understandable and supported by real demand, but sustainable shareholder value depends on converting stronger operating profits into cash and containing leverage.
Q2: Can Karman’s Forward Valuation Be Justified by Its $1.7B Backlog and 20%-25% Organic Growth Ambition?
- Analysis: Karman trades at approximately 40.66x trailing to and roughly 51.61x forward earnings. These multiples represent a substantial premium to conventional industrial manufacturing economics. Its backlog of approximately $1.7B, long-duration defense programs, and strong organic growth provide credible reasons for premium valuation. Nevertheless, backlog is not equivalent to realized revenue, and neither the timing nor the cash profitability of its conversion is guaranteed. A future-date comparison using projected FY2028 adjusted EBITDA suggests that investors continue to require sustained earnings expansion and substantial margins.
- Judgment: Overvalued — Karman’s growth premium is supported by strong operating evidence, but current valuation leaves limited room for execution setbacks.
Q3: How Much of Karman’s Revenue Growth Comes From Organic Demand Rather Than Acquisitions?
- Analysis: Q3 2026 total revenue increased approximately 65.6% YoY, while organic revenue growth was approximately 25%. This implies that acquisitions and changes in the consolidated business perimeter contributed substantially to reported expansion. The distinction matters because acquired revenue requires purchase consideration, integration effort, financing, and potential amortization charges. Organic growth is more directly informative about the expanding demand for the existing product portfolio. Karman’s approximately 25% organic growth remains strong even after separating acquisition contributions.
- Judgment: Positive — The operating business exhibits convincing underlying growth, although headline expansion overstates the purely organic trajectory.
Q4: Can Karman Convert Its $1.7B Backlog Into Sustainable Free Cash Flow?
- Analysis: Backlog provides meaningful visibility into future production, but depends on contractual schedules, manufacturing readiness, customer acceptance, and funding. Karman’s Q3 free cash flow of $13M shows that cash generation can improve materially during favorable periods. However, trailing FCF remained slightly negative due to investment and . Backlog growth can initially increase inventory, receivables, and contract assets before customer cash receipts arrive. The strongest investment outcome would combine substantial backlog conversion with improving working-capital efficiency.
- Judgment: Neutral — Backlog supports revenue visibility, but the cash-conversion thesis remains incompletely proven.
Q5: Does Karman Have a Sustainable Competitive Advantage Against Larger Defense Contractors?
- Analysis: Karman benefits from specialized manufacturing expertise, established program qualifications, and switching costs associated with mission-critical components. Larger defense contractors possess greater overall financial resources but often rely on specialized suppliers for narrowly defined engineering and manufacturing requirements. Karman’s merchant-supplier model allows participation across multiple prime contractors and programs. However, major customers retain purchasing leverage and can pursue second sourcing or internal manufacturing when economically attractive.
- Judgment: Positive — Technical qualification and program entrenchment create meaningful advantages, although Karman does not possess unchallengeable pricing power.
Q6: Will Karman’s European Expansion Through Walker Precision Improve Long-Term Returns?
- Analysis: Walker Precision strengthens Karman’s manufacturing capabilities in missile guidance, seeker, and control-related applications and expands access to European allied defense programs. The acquisition creates opportunities to offer additional capabilities to existing customers and enter new production relationships. Its economic success depends on revenue retention, manufacturing efficiencies, and return on acquisition capital. Integration complexity, local operating costs, and financing requirements could reduce the benefits.
- Judgment: Neutral to Positive — The acquisition strengthens strategic positioning, but incremental returns on invested capital have not yet been established.
Q7: How Important Is Karman’s THAAD-Related Long-Term Agreement to Its Growth Outlook?
- Analysis: Karman disclosed a significant seven-year agreement with Lockheed Martin supporting the THAAD program. Such agreements can improve production visibility, capacity planning, and customer relationships. They also support the strategic importance of Karman’s manufacturing capabilities in missile defense. However, an agreement’s nominal duration does not establish uniform annual revenue, guaranteed profitability, or immunity from procurement changes. The key economic tests are production volumes, contract margins, and cash conversion.
- Judgment: Positive — The agreement strengthens long-term demand visibility, but its precise financial contribution remains dependent on program execution.
Q8: Could Karman’s High Create Another Major Share-Price Squeeze?
- Analysis: A market-positioning snapshot indicated approximately 15.09M shares sold short and roughly 5.26 . The calculated short-interest percentage varies materially depending on which float definition is used. Karman’s 42.13% one-session rise on November 6 illustrates how rapidly price movements can develop when liquidity and sentiment change. Strong earnings, guidance increases, and concentrated short positioning can contribute to additional volatility. However, short covering is a trading mechanism, not a durable source of enterprise earnings.
- Judgment: Neutral — High short interest creates substantial upside and downside trading volatility, but does not independently improve intrinsic value.
Q9: Can Karman Maintain Approximately 30% Adjusted EBITDA Margins as Production Expands?
- Analysis: Karman reported approximately $61M of adjusted EBITDA on $201.62M of Q3 revenue, implying a margin of roughly 30.3%. Management’s FY2026 guidance supports a similar full-year profitability level. Sustaining these margins requires favorable product mix, adequate facility utilization, disciplined labor and material costs, and successful integration of acquisitions. Production expansion may generate , but new programs and manufacturing facilities can also require substantial upfront spending. Adjusted EBITDA excludes important costs that ultimately affect shareholder returns.
- Judgment: Positive with Conditions — Current operating performance supports strong margins, but their durability must be demonstrated alongside positive FCF.
Q10: What Would Make Karman a Stronger Long-Term Investment Over the Next 12 Months?
- Analysis: The strongest improvement would be a combination of continued organic growth near management’s 20%-25% objective, successful conversion of contracted backlog, sustained adjusted EBITDA margins near 30%, and materially stronger free cash flow. A reduction in net leverage without sacrificing profitable growth would improve financial resilience and justify a more durable valuation premium. Conversely, slower program conversion, rising borrowing requirements, or deterioration in cash margins would weaken the investment case even if reported revenue continued increasing. Future earnings releases should therefore be evaluated using both operating growth and cash-generation metrics.
- Judgment: Positive with Conditions — Karman has credible structural growth potential, but a stronger investment case requires better financial conversion and a more favorable relationship between valuation and demonstrated cash returns.